Latest tweets #esccongress


RT @Cardioinfo_it: Do sex differences exist in #cardiovascular disease? And which are the most dangerous CV complications during #pregnancy
RT @JGrapsa: Abstract submission is now OPEN: https://t.co/jbcMfvgICW Top of the top of science 📚 And a great opportunity to be a part of #
La parola chiave che apre la prima puntata di #1C1Y da #ESCCongress 2018 è #sostenibilità. Ne abbiamo parlato con L… https://t.co/db8fYCm2BR
La parola chiave che apre la prima puntata di #1C1Y da #ESCCongress 2018 è #sostenibilità. Ne abbiamo parlato con L… https://t.co/db8fYCm2BR
RT @JGrapsa: Abstract submission is now OPEN: https://t.co/jbcMfvgICW Top of the top of science 📚 And a great opportunity to be a part of #
RT @JGrapsa: Abstract submission is now OPEN: https://t.co/jbcMfvgICW Top of the top of science 📚 And a great opportunity to be a part of #…
RT @Cardioinfo_it: Torna anche quest'anno #1C1Y da #ESCcongress, per valorizzare gli spunti offerti dal Congresso dell'@escardio con interv…
RT @Cardioinfo_it: Torna anche quest'anno #1C1Y da #ESCcongress, per valorizzare gli spunti offerti dal Congresso dell'@escardio con interv…
Check out the important trial results for interventional cardiology from #ESCCongress and #TCT2018:… https://t.co/75WgjeYwIu
Check out the important trial results for interventional cardiology from #ESCCongress and #TCT2018:… https://t.co/75WgjeYwIu
Do sex differences exist in #cardiovascular disease? And which are the most dangerous CV complications during… https://t.co/hm5E18YCJo
Do sex differences exist in #cardiovascular disease? And which are the most dangerous CV complications during… https://t.co/hm5E18YCJo
RT @Cardioinfo_it: Torna anche quest'anno #1C1Y da #ESCcongress, per valorizzare gli spunti offerti dal Congresso dell'@escardio con interv…
RT @Cardioinfo_it: Torna anche quest'anno #1C1Y da #ESCcongress, per valorizzare gli spunti offerti dal Congresso dell'@escardio con interv…
Torna anche quest'anno #1C1Y da #ESCcongress, per valorizzare gli spunti offerti dal Congresso dell'@escardio con i… https://t.co/syM2t8OFT5
Torna anche quest'anno #1C1Y da #ESCcongress, per valorizzare gli spunti offerti dal Congresso dell'@escardio con i… https://t.co/syM2t8OFT5
RT @JGrapsa: Abstract submission is now OPEN: https://t.co/jbcMfvgICW Top of the top of science 📚 And a great opportunity to be a part of #
RT @JGrapsa: Abstract submission is now OPEN: https://t.co/jbcMfvgICW Top of the top of science 📚 And a great opportunity to be a part of #…
RT @NEJM: Results of the POET Trial, presented at #ESCCongress: Changing to oral antibiotic treatment in stabilized patients with left-side…
RT @NEJM: Results of the POET Trial, presented at #ESCCongress: Changing to oral antibiotic treatment in stabilized patients with left-side…
RT @ACCinTouch: ICYMI: Dr. @Vetrovec compiled important trial results for interventional cardiology from #ESCCongress and #TCT2018. Read he…
RT @ACCinTouch: ICYMI: Dr. @Vetrovec compiled important trial results for interventional cardiology from #ESCCongress and #TCT2018. Read he…
RT @ACCinTouch: ICYMI: Dr. @Vetrovec compiled important trial results for interventional cardiology from #ESCCongress and #TCT2018. Read he…
RT @ACCinTouch: ICYMI: Dr. @Vetrovec compiled important trial results for interventional cardiology from #ESCCongress and #TCT2018. Read he…
ICYMI: Dr. @Vetrovec compiled important trial results for interventional cardiology from #ESCCongress and #TCT2018.https://t.co/MIOlD4AR61
ICYMI: Dr. @Vetrovec compiled important trial results for interventional cardiology from #ESCCongress and #TCT2018.… https://t.co/MIOlD4AR61

close